UroGen Pharma
(NASDAQ:URGN)
$15.10
0[0.00%]
At close: Apr 15
$15.10
0[0.00%]
After Hours: 4:00PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary

UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.

Open$15.320
Close$15.100
Volume / Avg.661.676K / 369.222K
Day Range14.210 - 15.500
52 Wk Range8.690 - 24.130
Market Cap$515.244M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
52
Short Interest
13.28%
Days to Cover7.39

Recent News

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Avi Kapoor
Two Months After Hamas Attacks, Gaza Conflict Intensifies As Ceasefire Efforts Falter
Two months after Hamas attacks, US President Biden, UNSC & King of Jordan call for ceasefire. Israeli stocks rise, US envoy to UN against ceasefire. Investigations into civilian casualties & use of phosphorus munitions. UNSC to convene tomorrow.
Piero Cingari
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil.
Piero Cingari
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
2
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in innovative solutions for ur...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
URGN

FAQ

Q

How do I buy UroGen Pharma (URGN) stock?

A

You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are UroGen Pharma's (URGN) competitors?

A

There are no as such competitors for UroGen Pharma.

Q

What is the target price for UroGen Pharma (URGN) stock?

A

The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Thursday, April 4, 2024. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 257.62% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for UroGen Pharma (URGN)?

A

The stock price for UroGen Pharma (NASDAQ: URGN) is $15.1 last updated April 15, 2024 at 4:00 PM EDT.

Q

Does UroGen Pharma (URGN) pay a dividend?

A

There are no upcoming dividends for UroGen Pharma.

Q

When is UroGen Pharma (NASDAQ:URGN) reporting earnings?

A

UroGen Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is UroGen Pharma (URGN) going to split?

A

There is no upcoming split for UroGen Pharma.

Q

What sector and industry does UroGen Pharma (URGN) operate in?

A

UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.